LoboVault Home
 

A comparison of dental practitioners' knowledge of the adverse oral effects of pharmaceuticals; specifically, low-dose methotrexate, diltiazem, cyclosporine, istretinoin, and lisinopril

LoboVault

Please use this identifier to cite or link to this item: http://hdl.handle.net/1928/9320

A comparison of dental practitioners' knowledge of the adverse oral effects of pharmaceuticals; specifically, low-dose methotrexate, diltiazem, cyclosporine, istretinoin, and lisinopril

Show simple item record

dc.contributor.author Van Witzenburg, Melissa
dc.date.accessioned 2009-07-08T22:54:24Z
dc.date.available 2009-07-08T22:54:24Z
dc.date.issued 2009-07-08T22:54:24Z
dc.date.submitted May 2009
dc.identifier.uri http://hdl.handle.net/1928/9320
dc.description.abstract There are more than 15, 000 approved prescription and over-the-counter drugs, diagnostics, and intravenous supplementation products in the United States. Due to the increased number of patients using medications it is important that dental providers are aware of common adverse oral complications. The most commonly seen adverse oral effects of medications are xerostomia, gingival hypertrophy, angular cheilitis, and mucositis. The purpose of this study was to examine dental providers, “subjects” knowledge of adverse oral effects of low-dose methotrexate, diltiazem, cyclosporine, isotretinoin, and lisinopril. Four of the five hypotheses tested demonstrated high P-values, therefore; they were consistent with the null hypothesis. However, these four hypotheses yielded insight into areas of further study. When evaluating the number of continuing education hours that subjects participate in annually compared to their responses on the survey, a statistically significant difference was demonstrated. A P-value of 0.022 was obtained, with subjects participating in 26+ hours of continuing education scoring an average of 0.629 higher than those who participate in 25 or fewer hours of continuing education annually. Data suggests that further studies are needed to evaluate where students are instructed on adverse oral effects in an educational setting and how much time is spent on the subject matter. Other areas of further investigation would include a study of established dental providers and how could their attainment of knowledge improve. Most importantly this data highlights a deficiency in information regarding adverse oral effects. It is crucial that this topic be researched further and dental providers are educated on this subject matter to ensure the highest quality of care to dental patients. en_US
dc.language.iso en_US en_US
dc.subject low-dose methotrexate en_US
dc.subject diltiazem en_US
dc.subject cyclosporine en_US
dc.subject isotretinoin en_US
dc.subject lisinopril en_US
dc.subject mucositis en_US
dc.subject xerostomia en_US
dc.subject angular chelitis en_US
dc.subject gingival hypertrophy en_US
dc.subject.lcsh Dentistry--Practice--New Mexico.
dc.subject.lcsh Physician practice patterns--New Mexico.
dc.subject.lcsh Dental care--New Mexico--Evaluation.
dc.subject.lcsh Dental surveys--New Mexico.
dc.subject.lcsh Drug monitoring--New Mexico.
dc.subject.lcsh Drugs--Side effects.
dc.subject.lcsh Mouth--Effect of drugs on.
dc.subject.lcsh Teeth--Effect of drugs on.
dc.subject.lcsh Drug interactions.
dc.title A comparison of dental practitioners' knowledge of the adverse oral effects of pharmaceuticals; specifically, low-dose methotrexate, diltiazem, cyclosporine, istretinoin, and lisinopril en_US
dc.type Thesis en_US
dc.description.degree Master of Science, Dental Hygiene en_US
dc.description.level Masters en_US
dc.description.department Dental Hygiene en_US
dc.description.advisor Nathe, Christine
dc.description.committee-member Sanchez-Dils, Elaine
dc.description.committee-member Plese, Melissa


Files in this item

Files Size Format View
Electronic copy of thesis.pdf 1.408Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

UNM Libraries

Search LoboVault


Advanced Search

Browse

My Account